Skip to main content
Log in

Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The influence of two β-adrenoceptor antagonists, propranolol and pindolol, on the haemodynamic effects of papaverine, isoprenaline and noradrenaline was investigated in 9 male patients with first degree essential hypertension. Propranolol and pindolol were given according to a doubleblind, crossover scheme. Heart rate and blood pressure were measured before and after each treatment. Propranolol 670 µg/kg i. v. reduced the supine and standing systolic blood pressures by 2.3% and 1.6%, respectively. Similarly, the intravenous administration of pindolol 35 µg/kg reduced supine and standing systolic blood pressure by 5.5% and 8.3% respectively (clinically insignificant). Neither drug affected diastolic blood pressure. Following propranolol, there were moderate reductions in supine and standing heart rates, respectively by 24% and 20% (p<0.001). Similarly, but to a lesser extent, pindolol reduced supine and standing heart rate by 12% and 17% (p<0.001). The effects of papaverine, which, at 1.5 mg/kg i. v. reduced systolic blood pressure by 5–10% and increased heart rate by 8–15%, were not significantly influenced by the β-blockers. The blood pressure and heart rate responses to isoprenaline, on the other hand, were attenuated or inhibited by both β-blockers. While the β-blockers inhibited the β-adrenoceptor component of noradrenaline, the pressor component of noradrenaline, which is mediated through the α-adrenoceptors, was not influenced by propranolol, but was inhibited after pindolol. It is concluded that pindolol differs qualitatively from propranolol in that it inhibited both the α-and β-adrenoceptor effects of noradrenaline.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

BP:

blood pressure

ECG:

electrocardiogram

HR:

heart rate

ISA:

intrinsic sympathomimetic activity

References

  1. Cocco G, Burkart F, Chu D, Follath F (1978) Intrinsic Sympathomimetic Activity of β-adrenoceptor blocking agents. Eur J Clin Pharmacol 13:1–4

    Google Scholar 

  2. Cocco G, Strozzi C, Chu D (1977) I farmaci β-bloccanti sono stati introdotti in clinica 15 anni or sono: miti e realtà. Clin Ter 80:67–89

    Google Scholar 

  3. Dubach UC (1975) Was ist von Kardioselektivität und sympathikomimetischer Eigenwirkung von β-Rezeptorenblockern zu halten? Schweiz Med Rundschau 64:1239–1241

    Google Scholar 

  4. Ekul KJM, Shanks RG, Walsh MJ (1974) Observations on the effect of β-adrenoceptor blocking drugs on glyceryltrinitrate tachycardia. Br J Clin Pharmacol 1:19–26

    Google Scholar 

  5. Hansson L (1973) β-adrenergic blockade in essential hypertension. Effects of propranolol on hemodynamic parameters and plasma renin activity. Acta Med Scand (Suppl) 55:1–40

    Google Scholar 

  6. Law M, Rand MJ, Story DF (1974) Effects of β-adrenoceptor antagonists on testing and stimulation-induced efflux of noradrenaline from rabbit ear arteries. Proc Aust Physiol Pharmacol Soc 5:220–221

    Google Scholar 

  7. Leon DF, Shaver TA, Leonard JJ (1970) Reflex heart rate control in man. Am Heart J 80:729–739

    Google Scholar 

  8. Mazurkiewicz-Kwilecki IM (1970) Interactions of β-adrenergic blocking agents with noradrenaline in vascular smooth muscle. Eur J Pharmacol 11:155–162

    Google Scholar 

  9. Niarchos AP, Tahmooressi P, Tarazi RC: Comparison of heart rate and blood pressure response to amylnitrite, isoproterenol, and standing before and during acute β-adrenergic blockade with intravenous propranolol. Am Heart J 96:47–53

  10. Nussberger J, Vetter W, Krayenbuehl HP, Siegenthaler W (1975) Einfluß der β-Rezeptorenbehandlung mit Pindolol auf Plasmareninaktivität und linksventrikuläre Dynamik bei essentieller Hypertonie. Kardiol. Jahresversammlung, Schweiz. Gesellsch. Inn. Med., Luano June 5–7, 1975, communication No. 16, p 16

  11. O'Grady J, Oh V, Turner P (1978) Effects of propranolol and oxprenolol on the vasoconstrictor response to noradrenaline in the superficial hand vein in man. Eur J Clin Pharmacol 14:83–85

    Google Scholar 

  12. Saameli K (1967) Vergleichende Untersuchungen mit β-Rezeptorenblockern und Chinidin. Helv Physiol Pharmacol Acta 25: CR 432

  13. Somlyo AP, Somlyo AV (1969) Pharmacology of excitation-contraction coupling in vascular smooth muscle and in avian slow muscle. Fed Proc 28:1634–1642

    Google Scholar 

  14. Somlyo AV, Haeusler G, Somlyo AP (1970) β-adrenergic electrogenesis in vascular smooth muscle: effect of theophylline, external potassium and oligomycin. Fed Proc 29:613 (abstract no. 2062)

    Google Scholar 

  15. Somlyo AV, Haeusler G, Somlyo AP (1970) Cyclic adenosine monophosphate: potassium-dependent action on vascular smooth muscle membrane potential. Science 169:490–491

    Google Scholar 

  16. Thames MD, Kontos HA (1970) Mechanism of baroreceptor-induced changes in heart rate. Am J Physiol 218:251–256

    Google Scholar 

  17. Vatner SF, Higgins CB, Franklin D, Braunwald E (1972) Autonomic components of reflex tachycardia induced by hypotension. Physiologist 15:294

    Google Scholar 

  18. WHO classification, Technical Report Series No. 628, WHO, Geneva 1978, p 9

  19. Zweifler AJ, Hansson L (1976) Heart rate responses during treatment of hypertension with propranolol. The clinical usefulness of nitroglycerin test. Clin Pharmacol Ther 19:403–409

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chu, D., Cocco, G., Schweda, E. et al. Influence of propranolol and pindolol on the haemodynamic effects of papaverine, isoprenaline and noradrenaline in hypertensive patients. Eur J Clin Pharmacol 18, 141–146 (1980). https://doi.org/10.1007/BF00561581

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00561581

Key words

Navigation